COMPANY INFO
MEDTECH – Switzerland
Current stage: Scale-Up
COMPANY PROFILE
DistalMotion was founded in 2013 as a spin-off from the Robotics Lab of the Swiss Federal Institute of Technology in Lausanne (EPFL). The company is an international company founded and based in Lausanne, Switzerland that serves as a trusted partner to hospitals and clinics worldwide by providing reliable and precise robotic surgery systems – designed, developed and manufactured in Switzerland – at transparent and fair per-procedure cost
NEWS
Surgical robot gets greenlight to enter the US market
With the receipt of the De Novo Marketing Authorization from the US Food and Drug Administration Distalmotion is set to bring its surgical robot, Dexter into the US.
Distalmotion raises $150M to accelerate FDA approval and clinical experience
Distalmotion announced today the first closing of its USD 150 million financing. This significant fundraise reinforces the confidence of its existing investors led by Revival Healthcare Capital.
Dexter Series E: $90M to Make Sense of Robotic Surgery
Distalmotion, a Swiss-based medical device company, received European CE Mark for its surgical robot Dexter. Dexter combines the affordability of laparoscopy with the benefits of robotic surgery.
Distalmotion’s surgical robot is ready for clinical use
Distalmotion, a Swiss-based medical device company, received European CE Mark for its surgical robot Dexter. Dexter combines the affordability of laparoscopy with the benefits of robotic surgery.
Distalmotion – Dieser Gründer entwickelt einen Roboter für Operationen
Das Unternehmen Distalmotion will mit seinem OP-Roboter Dexter Kliniken in aller Welt erobern - und das Leben der Ärzte einfacher machen.
Interview with Michael Friedrich, Distalmotion CEO
Interview with Michael Friedrich, Distalmotion CEO